The current findings highlight the prognostic value of a more quantitative pretransplant assessment, which can help improve the patient selection process.
“We are in the process of analyzing some more outcomes of these pretransplant assessments, and developing a score that can, in conjunction with other predictive tools, help us improve pretransplant risk stratification and devise interventions that can improve the endurance and overall survival of the patients,” she concluded.
Dr. Rehman reported having no financial disclosures.
SOURCE: Rehman S et al., The 2018 BTM Tandem Meetings, Abstract 19.